These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 26177572)

  • 1. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
    Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
    Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
    Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
    Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
    Hirschowitz BI; Haber MM
    Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
    Song H; Zhu J; Lu D
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010623. PubMed ID: 25464111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
    Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
    Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
    Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
    Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
    Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
    Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach.
    Tsukamoto H; Mizoshita T; Sasaki M; Mizushima T; Tanida S; Ozeki K; Hirata Y; Shimura T; Kataoka H; Kamiya T; Nojiri S; Tsukamoto T; Tatematsu M; Joh T
    Asian Pac J Cancer Prev; 2011; 12(4):1049-54. PubMed ID: 21790250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Proton Pump Inhibitor Therapy,
    Veysey-Smith R; Moore AR; Murugesan SV; Tiszlavicz L; Dockray GJ; Varro A; Pritchard DM
    Front Endocrinol (Lausanne); 2021; 12():741887. PubMed ID: 34867785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
    Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
    Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use.
    Rais R; Trikalinos NA; Liu J; Chatterjee D
    Arch Pathol Lab Med; 2022 Mar; 146(3):366-371. PubMed ID: 34283890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric carcinoids after long-term use of a proton pump inhibitor.
    Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
    Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.
    Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL
    Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
    McCarthy DM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
    Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
    Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia.
    Waldum HL; Rehfeld JF
    Scand J Gastroenterol; 2019 Sep; 54(9):1118-1123. PubMed ID: 31524029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia.
    Robinson M
    Aliment Pharmacol Ther; 1999 Oct; 13 Suppl 5():5-10. PubMed ID: 10555603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor.
    Jianu CS; Lange OJ; Viset T; Qvigstad G; Martinsen TC; Fougner R; Kleveland PM; Fossmark R; Hauso Ø; Waldum HL
    Scand J Gastroenterol; 2012 Jan; 47(1):64-7. PubMed ID: 22087794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.
    Sanduleanu S; Stridsberg M; Jonkers D; Hameeteman W; Biemond I; Lundqvist G; Lamers C; Stockbrügger RW
    Aliment Pharmacol Ther; 1999 Feb; 13(2):145-53. PubMed ID: 10102943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does long-term profound inhibition of gastric acid secretion increase the risk of ECL cell-derived tumors in man?
    Waldum HL; Hauso Ø; Brenna E; Qvigstad G; Fossmark R
    Scand J Gastroenterol; 2016 Jul; 51(7):767-73. PubMed ID: 26872579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.